Which statement about Lumify is true?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

Which statement about Lumify is true?

Explanation:
Lumify contains brimonidine tartrate, which is an alpha-2 adrenergic receptor agonist. Activating these receptors in the eye causes constriction of the superficial conjunctival blood vessels, reducing redness. That’s why the true statement is that it is an alpha-2 agonist. Although alpha-2 agonists can lower intraocular pressure by decreasing aqueous humor production, Lumify is specifically indicated for redness relief, not for lowering IOP. It is not a prostaglandin analogue (that class includes drugs like bimatoprost) and it is not a beta-blocker (like timolol).

Lumify contains brimonidine tartrate, which is an alpha-2 adrenergic receptor agonist. Activating these receptors in the eye causes constriction of the superficial conjunctival blood vessels, reducing redness. That’s why the true statement is that it is an alpha-2 agonist.

Although alpha-2 agonists can lower intraocular pressure by decreasing aqueous humor production, Lumify is specifically indicated for redness relief, not for lowering IOP. It is not a prostaglandin analogue (that class includes drugs like bimatoprost) and it is not a beta-blocker (like timolol).

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy